Ken Griffin's position in Oruka Therapeutics is currently worth $72.9M. That's 0.05% of their equity portfolio (460th largest holding). The investor owns 2.69% of the outstanding Oruka Therapeutics stock. The stake costed the investor $25.9M, netting the investor a gain of 181% so far.